improve access

SCRS Talks How the Clinical Treatment Act is Increasing Diverse Access to Trials

SCRS Talks Podcast: How the Clinical Treatment Act is Increasing Diverse Access to Trials

In January 2022, the U.S. enacted legislation supporting our industry’s ability to sponsor more diverse, equitable, and inclusive clinical trials via the Clinical Treatment Act.  This law aims to create equal and increased access to clinical trials for more than 76 million Americans enrolled in Medicaid. SCRS sat down with Scott Gray, CEO of Clincierge, …

SCRS Talks Podcast: How the Clinical Treatment Act is Increasing Diverse Access to Trials Read More »

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials

Featured in Pharmaceutical Outsourcing, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations (CROs), …

Medicaid Mandate 2022: Striving for Equitable Access to Clinical Trials Read More »

Medicaid clinical trials routine costs

Medicaid Coverage of “Routine Costs” for Clinical Trials

Featured in Applied Clinical Trials, Scott Gray, CEO discusses changes to the Medicaid program and the impact it has on clinical trial participation. On Jan. 1, 2022, coverage of all “routine costs” associated with clinical trial participation became guaranteed for Medicaid beneficiaries through the Clinical Treatment Act. For clinical trial sponsors and clinical research organizations …

Medicaid Coverage of “Routine Costs” for Clinical Trials Read More »